Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -37.02% is 60% above its 5-year average of -92.89%, near the high end of its 5-year range (-456.89%–-31.58%).
As of the fiscal period ended Tuesday, June 30, 2026. 6.81% below its 12-month average of -34.66%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -37.02%.
RETURN ON INVESTED CAPITAL (ROIC)
-37.02%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-34.66%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-47.00%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-92.89%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-60.94%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
-81.35%
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
-87.80%
CURRENT VS TTM AVG
-6.81%
CURRENT VS 3Y AVG
+21.24%
CURRENT VS 5Y AVG
+60.15%
CURRENT VS 10Y AVG
+39.25%
CURRENT VS 15Y AVG
+54.49%
CURRENT VS 20Y AVG
+57.83%
SECTOR MEDIAN · HEALTHCARE
-35.64%
median of 838 covered companies
CURRENT VS SECTOR MEDIAN
-3.86%
vs the sector median at left
Madrigal Pharmaceuticals, Inc.
Market Cap
$11.52B
Return on Invested Capital (ROIC)
-37.02%
TTM Avg
-34.66%
3Y Avg
-47.00%
5Y Avg
-92.89%
Market Cap
$11.63B
Return on Invested Capital (ROIC)
11.18%
TTM Avg
11.30%
3Y Avg
9.75%
5Y Avg
9.57%
Market Cap
$11.34B
Return on Invested Capital (ROIC)
7.86%
TTM Avg
5.36%
3Y Avg
7.03%
5Y Avg
8.47%
Market Cap
$10.96B
Return on Invested Capital (ROIC)
4.76%
TTM Avg
4.09%
3Y Avg
3.90%
5Y Avg
4.30%
Market Cap
$10.84B
Return on Invested Capital (ROIC)
1.40%
TTM Avg
5.80%
3Y Avg
4.23%
5Y Avg
2.43%
Market Cap
$10.78B
Return on Invested Capital (ROIC)
-24.57%
TTM Avg
-32.39%
3Y Avg
-30.66%
5Y Avg
-30.79%
Market Cap
$12.37B
Return on Invested Capital (ROIC)
13.42%
TTM Avg
12.59%
3Y Avg
14.85%
5Y Avg
11.33%
Market Cap
$10.69B
Return on Invested Capital (ROIC)
11.74%
TTM Avg
10.95%
3Y Avg
8.97%
5Y Avg
9.05%
Market Cap
$12.41B
Return on Invested Capital (ROIC)
8.97%
TTM Avg
4.70%
3Y Avg
4.24%
5Y Avg
4.03%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Madrigal Pharmaceuticals, Inc. (MDGL) | $11.52B | -37.02% | -34.66% | -47.00% | -92.89% |
| DaVita Inc. (DVA)vs › | $11.63B | 11.18% | 11.30% | 9.75% | 9.57% |
| Bio-Techne Corporation (TECH)vs › | $11.34B | 7.86% | 5.36% | 7.03% | 8.47% |
| The Cooper Companies, Inc. (COO)vs › | $10.96B | 4.76% | 4.09% | 3.90% | 4.30% |
| BioMarin Pharmaceutical Inc. (BMRN)vs › | $10.84B | 1.40% | 5.80% | 4.23% | 2.43% |
| Twist Bioscience Corporation (TWST)vs › | $10.78B | -24.57% | -32.39% | -30.66% | -30.79% |
| Encompass Health Corporation (EHC)vs › | $12.37B | 13.42% | 12.59% | 14.85% | 11.33% |
| Universal Health Services, Inc. (UHS)vs › | $10.69B | 11.74% | 10.95% | 8.97% | 9.05% |
| BrightSpring Health Services, Inc. Common Stock (BTSG)vs › | $12.41B | 8.97% | 4.70% | 4.24% | 4.03% |
| ICON Public Limited Company (ICLR)vs › | $12.44B | 4.80% | 6.92% | 6.32% | 7.02% |
ROIC
-37.0%
ROE
-62.1%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -37.02% |
| 2026-03-31 | -35.20% |
| 2025-12-31 | -31.58% |
| 2025-09-30 | -31.67% |
| 2025-06-30 | -37.83% |
| 2025-03-31 | -51.26% |
| 2024-12-31 | -57.03% |
| 2024-09-30 | -61.21% |
| 2024-06-30 | -54.41% |
| 2024-03-31 | -46.92% |
| 2023-12-31 | -72.89% |
| 2023-09-30 | -252.08% |
| 2023-06-30 | -163.00% |
| 2023-03-31 | -134.27% |
| 2022-12-31 | -119.01% |
| 2022-09-30 | -456.89% |
| 2022-06-30 | -193.09% |
| 2022-03-31 | -169.21% |
| 2021-12-31 | -123.40% |
| 2021-09-30 | -100.88% |
| 2021-06-30 | -85.92% |
| 2021-03-31 | -84.94% |
| 2020-12-31 | -85.96% |
| 2020-09-30 | -61.01% |
| 2020-06-30 | -41.53% |
| 2020-03-31 | -29.77% |
| 2019-12-31 | -22.78% |
| 2019-09-30 | -18.03% |
| 2019-06-30 | -14.56% |
| 2019-03-31 | -11.03% |
| 2018-12-31 | -8.53% |
| 2018-09-30 | -7.28% |
| 2018-06-30 | -6.67% |
| 2018-03-31 | -18.66% |
| 2017-12-31 | -17.59% |
| 2017-09-30 | -56.78% |
| 2017-06-30 | -58.67% |
| 2017-03-31 | -90.58% |
| 2016-12-31 | -86.73% |
| 2016-09-30 | -91.18% |
| 2016-06-30 | -90.64% |
| 2016-03-31 | -115.13% |
| 2015-12-31 | -286.87% |
| 2015-09-30 | -114.61% |
| 2015-06-30 | -101.22% |
| 2015-03-31 | -141.05% |
| 2014-12-31 | -106.27% |
| 2014-09-30 | -87.59% |
| 2014-06-30 | -97.15% |
| 2014-03-31 | -152.69% |
| 2013-12-31 | -120.86% |
| 2013-09-30 | -214.65% |
| 2013-06-30 | -126.04% |
| 2013-03-31 | -83.05% |
| 2012-12-31 | -69.68% |
| 2012-09-30 | -114.89% |
| 2012-06-30 | -139.06% |
| 2012-03-31 | -97.57% |
| 2011-12-31 | -144.64% |
| 2011-09-30 | -105.30% |
| 2011-06-30 | -77.90% |
| 2011-03-31 | -123.97% |
| 2010-12-31 | -98.84% |
| 2010-09-30 | -45.49% |
| 2009-03-31 | -202.23% |
| 2008-12-31 | -201.41% |
| 2008-09-30 | -127.68% |
| 2008-06-30 | -106.12% |
| 2008-03-31 | -76.42% |
| 2007-12-31 | -63.50% |
| 2007-09-30 | -140.80% |
| 2007-06-30 | -106.69% |
| 2007-03-31 | -78.99% |
| 2006-12-31 | -126.04% |
| 2006-09-30 | -105.02% |
| 2005-12-31 | -148.95% |
